Ubiquitin Homeostasis Is Disrupted in TDP-43 and FUS Cell Models of ALS by Farrawell, Natalie E et al.
University of Wollongong 
Research Online 
Faculty of Science, Medicine and Health - 
Papers: Part B Faculty of Science, Medicine and Health 
January 2020 
Ubiquitin Homeostasis Is Disrupted in TDP-43 and FUS Cell Models of ALS 
Natalie E. Farrawell 
University of Wollongong, nfarrawe@uow.edu.au 
Luke McAlary 
University of Wollongong, lmcalary@uow.edu.au 
Jeremy Lum 
University of Wollongong, jlum@uow.edu.au 
Christen Chisholm 
University of Wollongong, cgc914@uowmail.edu.au 
Sadaf T. Warraich 
See next page for additional authors 
Follow this and additional works at: https://ro.uow.edu.au/smhpapers1 
Publication Details Citation 
Farrawell, N. E., McAlary, L., Lum, J., Chisholm, C., Warraich, S. T., Blair, I., Vine, K. L., Saunders, D., & 
Yerbury, J. J. (2020). Ubiquitin Homeostasis Is Disrupted in TDP-43 and FUS Cell Models of ALS. Faculty 
of Science, Medicine and Health - Papers: Part B. Retrieved from https://ro.uow.edu.au/smhpapers1/1743 
Research Online is the open access institutional repository for the University of Wollongong. For further information 
contact the UOW Library: research-pubs@uow.edu.au 
Ubiquitin Homeostasis Is Disrupted in TDP-43 and FUS Cell Models of ALS 
Abstract 
2020 The Author(s) A major feature of amyotrophic lateral sclerosis (ALS) pathology is the accumulation 
of ubiquitin (Ub) into intracellular inclusions. This sequestration of Ub may reduce the availability of free 
Ub, disrupting Ub homeostasis and ultimately compromising cellular function and survival. We previously 
reported significant disturbance of Ub homeostasis in neuronal-like cells expressing mutant SOD1. Here, 
we show that Ub homeostasis is also perturbed in neuronal-like cells expressing either TDP-43 or FUS. 
The expression of mutant TDP-43 and mutant FUS led to UPS dysfunction, which was associated with a 
redistribution of Ub and depletion of the free Ub pool. Redistribution of Ub is also a feature of sporadic 
ALS, with an increase in Ub signal associated with inclusions and no compensatory increase in Ub 
expression. Together, these findings suggest that alterations to Ub homeostasis caused by the misfolding 
and aggregation of ALS-associated proteins play an important role in the pathogenesis of ALS. 
Publication Details 
Farrawell, N., McAlary, L., Lum, J., Chisholm, C., Warraich, S., Blair, I., Perrow, K., Saunders, D. & Yerbury, J. 
(2020). Ubiquitin Homeostasis Is Disrupted in TDP-43 and FUS Cell Models of ALS. iScience, 23 (11), 
Authors 
Natalie E. Farrawell, Luke McAlary, Jeremy Lum, Christen Chisholm, Sadaf T. Warraich, Ian Blair, Kara L. 
Vine, Darren Saunders, and Justin J. Yerbury 
This journal article is available at Research Online: https://ro.uow.edu.au/smhpapers1/1743 
iScience
Article
Ubiquitin Homeostasis Is Disrupted in TDP-43 and
FUS Cell Models of ALS
Natalie E.
Farrawell, Luke
McAlary, Jeremy
S. Lum, ..., Kara L.
Vine, Darren N.
Saunders, Justin J.
Yerbury
jyerbury@uow.edu.au
HIGHLIGHTS
The expression of TDP-
43M337V and FUSR495X
causes UPS dysfunction in
NSC-34 cells
The aggregation of TDP-
43M337V and FUSR495X
depletes the free Ub pool
in cells
Ub homeostasis is altered
in spinal cord tissue from
patients with sALS
Perturbed Ub
homeostasis is a common
feature of ALS
Farrawell et al., iScience 23,
101700
November 20, 2020 ª 2020
The Author(s).
https://doi.org/10.1016/
j.isci.2020.101700
ll
OPEN ACCESS
iScience
Article
Ubiquitin Homeostasis Is Disrupted
in TDP-43 and FUS Cell Models of ALS
Natalie E. Farrawell,1,2 Luke McAlary,1,2 Jeremy S. Lum,1,2 Christen G. Chisholm,1,2 Sadaf T. Warraich,3
Ian P. Blair,3 Kara L. Vine,1,2 Darren N. Saunders,4 and Justin J. Yerbury1,2,5,*
SUMMARY
A major feature of amyotrophic lateral sclerosis (ALS) pathology is the accumula-
tion of ubiquitin (Ub) into intracellular inclusions. This sequestration of Ub may
reduce the availability of free Ub, disrupting Ub homeostasis and ultimately
compromising cellular function and survival. We previously reported significant
disturbance of Ub homeostasis in neuronal-like cells expressing mutant SOD1.
Here, we show that Ub homeostasis is also perturbed in neuronal-like cells
expressing either TDP-43 or FUS. The expression of mutant TDP-43 and mutant
FUS led to UPS dysfunction, which was associated with a redistribution of Ub
and depletion of the free Ub pool. Redistribution of Ub is also a feature of
sporadic ALS, with an increase in Ub signal associated with inclusions and no
compensatory increase in Ub expression. Together, these findings suggest that
alterations to Ub homeostasis caused by the misfolding and aggregation of
ALS-associated proteins play an important role in the pathogenesis of ALS.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the pro-
gressive loss of motor neurons in the spinal cord and motor cortex, resulting in paralysis and eventually
death typically by respiratory failure (Hardiman et al., 2017). The cause(s) of most cases of ALS remains
largely unknown (sporadic ALS; sALS), with only approximately 10% of all cases having a clear inherited ge-
netic cause (familial ALS; fALS). There are now over 25 genes known to be associated with ALS (Nguyen
et al., 2018), which can be broadly classified into three functional groups including RNA metabolism, traf-
ficking, and protein degradation that have each been proposed to perturb proteome homeostasis (Yerbury
et al., 2020). Mutations in RNA-binding proteins TAR DNA-binding protein 43 (TDP-43) and fused-in-
sarcoma (FUS) account for a small proportion of fALS cases (5%) (Chen et al., 2013). However, the
wild-type forms of both TDP-43 and FUS are both strongly associated with the etiology of sALS and fron-
totemporal dementia (FTD) (Neumann et al., 2006, 2009; Arai et al., 2006; Blair et al., 2010; Lai et al., 2011),
suggesting these genes play a pivotal role in disease pathology. A growing list of genes encoding compo-
nents or regulators of the ubiquitin-proteasome system (UPS) and autophagy implicate defective protein
degradation in ALS. Mutations in VCP (Johnson et al., 2010), SQSTM1 (Fecto et al., 2011), UBQLN2 (Deng
et al., 2011), OPTN (Maruyama et al., 2010), TBK1 (Cirulli et al., 2015), CCNF (Williams et al., 2016), and
DNAJC7 (Farhan et al., 2020) have all been associated with ALS and are all components of cellular protein
degradation machinery.
A hallmark of many neurodegenerative diseases, including FTD and ALS, is the abnormal accumulation of
proteins into insoluble aggregates or inclusions (Yerbury et al., 2016). It remains to be determined whether
these aggregates are a cause or consequence of disease. Evidence suggests that a correlation exists be-
tween aggregate load and motor neuron loss in ALS (Ticozzi et al., 2010; Brettschneider et al., 2014; Gior-
dana et al., 2010), and our previous work has shown that mutant superoxide dismutase 1 (SOD1) aggrega-
tion propensity correlates with toxicity in the neuronal-like NSC-34 cells (McAlary et al., 2016). Protein
inclusions are heterogeneous in their protein composition and contain not just pathological proteins but
also molecular chaperones (Sherman and Goldberg, 2001; Yerbury and Kumita, 2010), UPS components
(Huang and Figueiredo-Pereira, 2010), and other proteins susceptible to aggregation (Ciryam et al.,
2013, 2015). In ALS, the composition of inclusions varies depending on the ALS subtype (sALS versus
fALS) and even the underlying mutated gene itself. For example, a majority of sALS and fALS cases have
inclusions positive for TDP-43 (Turner et al., 2013) but not SOD1 or FUS; however, SOD1- or FUS-associated
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fALS cases show exclusive deposition of SOD1 and FUS respectively, with no TDP-43 immunoreactivity. In
addition to the variation in composition, there is evidence that these different inclusions form by distinct
processes in cells (Farrawell et al., 2015). The deposition of specific pathological proteins in different cases
suggests that the cellular toxicity may be a result of the sequestration of vital proteins into the inclusions
affecting their normal function. Accordingly, we have shown that the sub-proteome that co-aggregates
with SOD1, TDP-43, and FUS is composed of supersaturated proteins (Ciryam et al., 2017), with cellular con-
centrations that exceed their predicted solubility (Ciryam et al., 2013, 2015). These results are consistent
with a collapse in the proteostasis capacity of motor neurons in ALS, which is not surprising given that mo-
tor neurons have been shown to be particularly susceptible to UPS stress (Bax et al., 2019). Moreover, motor
neurons also have a reduced UPS capacity (Brockington et al., 2013) and amore metastable proteome (Yer-
bury et al., 2019) when compared with ALS-resistant oculomotor neurons, making them particularly
vulnerable.
The sequestration of Ub into inclusions is common to all forms of ALS, regardless of the underlying
genetics. Ub is best known for its role in targeting proteins for degradation via the proteasome, but it
also plays essential roles in a variety of cellular processes including signal transduction, endocytosis, tran-
scription, and DNA repair (Hershko and Ciechanover, 1998; Chen and Sun, 2009). Ub is covalently linked to
target proteins through a highly ordered, three-step enzymatic cascade, with differences in Ub chain length
and topology determining the fate of the target protein (Pickart, 2001). Inside cells, Ub exists in a dynamic
equilibrium between free unconjugated Ub and Ub conjugated in chains (Dantuma et al., 2006; Groothuis
et al., 2006). The pool of free Ub is limited and is maintained through controlling Ub expression and the
rates of Ub degradation and by recycling Ub from its target substrates. The availability of Ub is particularly
important in neurons as it has been shown to regulate differentiation andmany aspects of synaptic function
including neurogenesis, neuronal excitability, neurotransmission, and synapse formation and elimination
(Bax et al., 2019; Mabb and Ehlers, 2010; Kawabe and Brose, 2011). The sequestration of Ub into inclusions
may also reduce the availability of free Ub, which is essential for cellular function and survival (Groothuis
et al., 2006; Ben Yehuda et al., 2017).
Recently, we showed altered Ub homeostasis in a mutant SOD1 cell model of ALS (Farrawell et al., 2018).
The aggregation of pathogenic SOD1A4V in NSC-34 cells led to alterations in UPS activity and redistribu-
tion of Ub, disrupting Ub homeostasis and causing mitochondrial dysfunction. It is not currently known if
perturbed Ub homeostasis is common to all forms of ALS. Here, we show that Ub homeostasis is disrup-
ted in multiple cell models of ALS. The expression of the mutant forms of ALS-associated proteins, TDP-
43 and FUS, caused UPS dysfunction in cells, which was associated with a redistribution of Ub and
decreased levels of free monomeric Ub. Increased levels of Ub were also found to be associated with
inclusions in postmortem tissue from patients with sALS, confirming that redistribution of Ub is also a
feature of sALS. Importantly, this work highlights that misfolded proteins and aggregates associated
with ALS contribute to UPS dysfunction and that Ub homeostasis is a key target for monitoring patholog-
ical changes in ALS.
RESULTS
TDP-43 and FUS Aggregates Contain K48 and K63-Linked Ubiquitin Chains
K48- and K63-linked polyubiquitin chains are the two most abundant chain types known to target pro-
teins for degradation by the UPS or direct them for removal by autophagy, respectively. We have previ-
ously shown that SOD1A4V aggregates contain both UbK48 and UbK63 chains and that Ub was present
from the earliest stages of aggregation (Farrawell et al., 2018), whereas TDP-43 and FUS aggregates
are ubiquitinated relatively late by comparison (Farrawell et al., 2015). Here, we show that both
TDP-43M337V aggregates (Figure 1A) and FUSR495X aggregates (Figure 1B) contain both UbK48 and
UbK63 polymers. In fact, there was a large amount of overlap between TDP-43M337V aggregates and
both UbK48 and UbK63, with 60% of the TDP-43M337V aggregates identified within transfected cells
colocalized with UbK48 and 73% of TDP-43M337V aggregates colocalized with UbK63. Furthermore, the in-
tensity of UbK48 and UbK63 signal associated with TDP-43M337V aggregates was significantly higher than
the signal observed to be associated with soluble TDP-43 M337V (Figure 1C). In cells containing FUSR495X
aggregates,  55% of FUSR495X aggregates were positive for UbK48 or UbK63 and the intensity of UbK48
and UbK63 staining was significantly greater in these aggregates when compared with areas containing
soluble FUS (Figure 1D).
ll
OPEN ACCESS
2 iScience 23, 101700, November 20, 2020
iScience
Article
Mutations in TDP-43 and FUS Cause UPS Dysfunction
We have previously shown that cells containing SOD1A4V aggregates have a dysfunctional UPS, as evi-
denced by the accumulation of significantly higher amounts of the fluorescent UPS reporter tdTomatoCL1
compared with cells expressing SOD1WT (Farrawell et al., 2018). To investigate whether cells expressing
ALS-associated mutant TDP-43 or FUS have a dysfunctional UPS, we co-transfected NSC-34 cells with
TDP-43-GFP, FUS-GFP, or tGFP and tdTomatoCL1 and measured tdTomatoCL1 accumulation in the pres-
ence of increasing concentrations of MG132 by flow cytometry. Cells expressing TDP-43WT and TDP-
43M337V showed a dose-dependent increase in tdTomatoCL1 signal with MG132 treatment, which was
significantly higher than the signal observed in cells expressing the tGFP control at all the concentrations
tested (Figure 2A). Modest increases in tdTomatoCL1 signal were observed with increasing MG132 concen-
trations in cells expressing the tGFP control (Figure S1), suggesting that UPS function was not completely
impaired at the concentrations tested. Although cells expressing TDP-43M337V exhibited higher levels of
tdTomatoCL1 fluorescence compared with cells expressing TDP-43WT, this increase was only significant
at the highest concentration of MG132 tested. In contrast, cells expressing FUSR495X exhibited significantly
higher levels of tdTomatoCL1 signal than cells expressing FUSWT at all the concentrations tested (Figure 2B).
Together, these results suggest that the overexpression of ALS-associated TDP-43 and FUS causes UPS
dysfunction.
Ubiquitin Pools Are Disturbed in Cells Expressing ALS Mutants of TDP-43 and FUS
To determine whether the UPS dysfunction observed in cells expressing mutant TDP-43 and mutant FUS
was associated with altered Ub homeostasis, we assessed the mobility and distribution of Ub in cells using
fluorescence recovery after photo bleaching (FRAP) (Axelrod et al., 1976; Dantuma et al., 2006). By bleach-
ing regions of interest in the nucleus and cytoplasm of cells co-expressing mCherry-Ub and TDP-43-GFP or
FUS-GFP (Figure S2), we could measure the recovery of mCherry-Ub into these regions to determine the
rate of nucleocytoplasmic Ub diffusion and cellular availability of mobile Ub. In the case of cells expressing
Figure 1. TDP-43 and FUS Aggregates Contain K48 and K63-Linked Ubiquitin Chains
NSC-34 cells transfected with mutant TDP-43-GFP (A) or mutant FUS-GFP (B) were fixed, permeabilized, and stained for
UbK48 and UbK63 polymers 48 h post transfection. The mean fluorescence intensity of UbK48 and UbK63 associated with
soluble and insoluble TDP-43M337V (C) or FUSR495X (D) was quantified using ImageJ. Data shown are mean G SD (n = 17
TDP-43/UbK48, n = 25 TDP-43/UbK63, n = 19 FUS/UbK48, n = 25 FUS/UbK63) and statistical significance between groups was
determined using an unpaired Student’s t test (****p < 0.0001). Scale bars represent 10 mm.
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mutant TDP-43M337V-GFP, we examined two subpopulations of cells, those expressing soluble TDP-
43M337V-GFP and those containing insoluble TDP-43M337V-GFP aggregates (defined as bright fluorescent
puncta > 2 mm). This distinction between subpopulations was not made in cells expressing FUSR495X-
GFP, as the majority of FUSR495X-GFP mislocalizes to the cytoplasm where it forms small foci and larger ag-
gregates. For this set of experiments, cells containing large FUSR495X-GFP aggregates were selected for
FRAP.
Patterns of Ub recovery for cells expressing both TDP-43-GFP (Figure 3A) and FUS-GFP (Figure 3B) were
similar to those observed previously with NSC-34 cells expressing SOD1-GFP (Farrawell et al., 2018), in
that levels of cytoplasmic recovery were higher than levels of recovery in the nucleus, indicating increased
Ub mobility. However, cells expressing soluble TDP-43M337V-GFP appeared to have slightly lower levels of
cytoplasmic recovery when compared with other cell populations expressing TDP-43-GFP and the tGFP
control (Figure 3A). Cells expressing either FUSWT-GFP or FUSR495X-GFP both had slightly lower levels of
cytoplasmic recovery in comparison with the tGFP control (Figure 3B), suggesting differences in the levels
of mobile Ub. After calculating the mean half-life of recovery (T1/2), significant increases were observed in
the cytoplasm of cells containing insoluble TDP-43M337V-GFP and in the nucleus of cells expressing FUSWT-
GFP when compared with the relevant tGFP control (Figure 3C), suggesting that the kinetics of Ub diffusion
is altered in these cells (presumably as Ub is being incorporated into larger complexes). When the amount
(%) of mobile Ub available to cells was quantified, no significant differences were observed between pop-
ulations expressing TDP-43-GFP. However, cells expressing both FUSWT-GFP and FUSR495X-GFP had
significantly lower levels of mobile Ub in the cytoplasm in comparison with the tGFP control (Figure 3D).
Free Ubiquitin Availability Is Lowered in Cells Expressing ALS Mutants of TDP-43 and FUS
To test whether the expression of TDP-43-GFP and FUS-GFP altered the amount of free monomeric Ub in
cells, we fractionated cell lysates of NSC-34 cells expressing either wild-type or mutant TDP-43-GFP and
FUS-GFP and analyzed the relative amount of monomeric Ub by western blotting (Figure S3). Similar to
our previous findings in SOD1-GFP-transfected cells (Farrawell et al., 2018), we were unable to detect sig-
nificant differences in free Ub levels using this method, most likely as this analysis represents a measure-
ment of both transfected and non-transfected cells in culture. Therefore, we examined the monomeric
Ub pool in cells expressing TDP-43-GFP and FUS-GFP by fluorescence recovery after nuclear photobleach-
ing (FRANP) (Farrawell et al., 2018). Using the nuclear pore as a molecular sieve, we bleached the entire
nucleus of cells co-expressing mCherry-Ub and TDP-43-GFP (Figures 4A and S4A) or FUS-GFP (Figures
4B and S4B) and monitored the diffusion of monomeric mCherry-Ub back into the nucleus. We observed
a significant decrease in the amount of monomeric Ub available to cells containing insoluble TDP-43M337V-
GFP aggregates, but there were no significant differences in the levels of monomeric Ub between cells ex-
pressing TDP-43WT-GFP, soluble TDP-43M337V–GFP, and the tGFP control (Figure 4C). A significant
decrease in monomeric Ub levels was also observed in cells expressing FUSR495X-GFP in comparison
with cells expressing FUSWT-GFP and tGFP (Figure 4C).
Figure 2. ALS Mutant TDP-43 and ALS Mutant FUS Alter UPS Activity in Living Cells
Dose-dependent response of UPS activity (tdTomatoCL1 fluorescence) in NSC-34 cells co-transfected with TDP-43-GFP
(A) or FUS-GFP (B) after overnight treatment (18 h) with the proteasome inhibitor, MG132. Data represent mean
tdTomatoCL1 fluorescence GSEM (n = 3) *p < 0.05, ***p < 0.001 indicate significant difference to WT (two-way ANOVA
with Bonferroni post-test). See also Figure S1.
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To determine whether TDP-43-GFP and FUS-GFP expression also alters the endogenous monomeric Ub
pool, we used the probe tUI-HA, which is designed to bind strongly and specifically to free Ub (Choi
et al., 2019). Using confocal microscopy, we confirmed the specificity and sensitivity of this probe for
free Ub by measuring tUI-HA levels in NSC-34 cells treated with the E1/UBA1 inhibitor TAK-243 (Hyer
et al., 2018). We observed a time-dependent increase in tUI-HA fluorescence in cells incubated with the
E1 inhibitor compared with cells treated with the DMSO control (Figure S5), consistent with previous re-
ports (Choi et al., 2019) and confirming the specificity of the tUI-HA probe for free Ub. We then measured
tUI-HA fluorescence in NSC-34 cells transfected with TDP-43-GFP or FUS-GFP (Figure 5A) and observed a
significant reduction in tUI-HA fluorescence in cells expressing TDP-43M337V-GFP or FUSR495X-GFP when
compared with cells expressing TDP-43WT-GFP or FUSWT-GFP (Figure 5B). To test whether the aggregation
of TDP-43M337V-GFP would also deplete the levels of monomeric Ub available to cells, we manually segre-
gated cells expressing TDP-43M337V-GFP into insoluble and soluble populations before quantifying tUI-HA
fluorescence. Cells containing insoluble aggregates of TDP-43M337V-GFP were found to have significantly
Figure 3. Ubiquitin Distribution Is Altered in Cells Expressing ALS Mutants of TDP-43 and FUS
(AC) NSC-34 cells co-transfected with TDP-43-GFP (A) or FUS-GFP (B) and mCherry-Ub were photobleached in either
the nucleus or cytoplasm and recovery of Ub fluorescence was monitored for 120 s. Data shown are meansG SEM (nR 9,
combined from three independent experiments). Scale bars represent 10 mm. (C) The mean half-life of mCherry-Ub
recovery (T1/2) was measured in both the nucleus and cytoplasm of NSC-34 cells co-transfected with either TDP-43-GFP or
FUS-GFP. Data shown are means G SEM combined from three independent experiments (nR 9). Two-way ANOVA with
Bonferroni post-test was used to compare differences to the tGFP control (**p ˂ 0.01).
(D) Quantification of the proportion of mobile Ub in the nucleus and cytoplasm of cells expressing either TDP-43-GFP or
FUS-GFP. Data shown are means G SEM combined from three independent experiments (n R 9). *p ˂ 0.05, **p ˂ 0.01
indicate significant difference to tGFP control (two-way ANOVA with Bonferroni post-test).
See also Figure S2.
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lower levels of tUI-HA fluorescence in comparison with cells expressing soluble TDP43M337V-GFP or TDP-
43WT-GFP (Figure 5C). These data indicate that the expression and aggregation of mutant TDP-43 and
mutant FUS decrease the cellular availability of endogenous free monomeric Ub and are consistent with
observations using mCherry labeled Ub reporter (above).
Ubiquitin Homeostasis in ALS Spinal Cord
Inclusions consisting primarily of ubiquitinated and aggregated TDP-43 are a pathological hallmark of
sALS. Having shown that the aggregation of TDP-43 in neuronal-like cells resulted in substantial disruption
to Ub homeostasis via sequestration of cellular Ub and significant depletion of free monomeric Ub (above),
we next sought to interrogate spinal cord motor neurons from sALS postmortem tissue for evidence of per-
turbed Ub homeostasis. We first probed for both TDP-43 and Ub and confirmed that the distribution of Ub
was dispersed evenly throughout spinal cord motor neurons in the absence of TDP-43 inclusions (Fig-
ure 6A). In contrast, we observed a significant increase in Ub fluorescence associated with TDP-43 aggre-
gates in cells containing inclusions (Figures 6A, 6B, and S6), consistent with the results of our cell culture
models (above). To investigate potential increases in Ub gene expression to compensate for the depletion
of free Ub following the accumulation of Ub into inclusions, we analyzedmicrodissected lumbar spinal cord
ventral horn cells from 11 patients with sALS and controls (D’Erchia et al., 2017). Of the four genes encoding
Ub (UBB, UBC, UBA52, and RPS27), only UBB was significantly reduced in sALS (Figure 6C), but when the
expression of all four Ub genes are considered together, there is no overall difference in Ub expression be-
tween sALS and controls.
A broader analysis of genes involved in the maintenance of Ub homeostasis (predominantly genes control-
ling UPS and autophagy) showed significant differences in the relative expression of a number of genes
encoding Ub ligases, de-ubiquitinase enzymes (DUBs), and proteases between ALS and control neurons.
We observed a pattern of generally decreased expression of UPS genes in ALS (Figure 6D, Tables S1 and
S2). We hypothesize that the decrease in expression across the Ub ligases and DUBs, along with the accu-
mulation of Ub chains on soluble and insoluble proteins, would act in concert to reduce the pool of free
monomeric Ub in sALS (Figure 6E).
DISCUSSION
Ub is integral to neuronal health and function as it regulates essential cellular processes including protein
quality control, protein trafficking, cell cycle regulation, and DNA repair (Hershko and Ciechanover, 1998;
Chen and Sun, 2009). The accumulation of Ub-positive inclusions is a hallmark of ALS pathology (Leigh
Figure 4. Reduced Levels of Free Monomeric Ubiquitin in NSC-34 Cells Expressing Mutant TDP-43 and Mutant
FUS
(A and B) The entire nucleus of NSC-34 cells co-expressing TDP-43-GFP (A) or FUS-GFP (B) and mCherry-Ub was
photobleached, and the recovery of nuclear Ub was monitored as a proportion of cytoplasmic fluorescence for 120 s. Data
represent meanG SEM (nR 10 TDP-43, nR 12 FUS, combined from three independent experiments). Scale bars, 10 mm.
(C) The percentage of mobile Ub in the nucleus at the final read was quantified as a proportion of cytoplasmic
fluorescence. Data represent meanG SEM (nR 10 TDP-43, nR 12 FUS, combined from three independent experiments).
One-way ANOVA with a Tukey’s multiple comparison post-test was used to determine statistical significance compared
with tGFP control (**p ˂ 0.01).
See also Figure S4.
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et al., 1991), and the associated sequestration of Ub into inclusions likely disrupts Ub homeostasis by
depleting the free Ub pool to levels where cellular functions are severely compromised and ultimately
result in cell death. We recently showed that SOD1A4V aggregation caused UPS dysfunction through deple-
tion of the free Ub pool and subsequent disruption of Ub homeostasis (Farrawell et al., 2018). To determine
if regulation of Ub homeostasis is perturbed in other models of ALS, we examined the distribution of Ub in
cell models expressing ALS-associated proteins TDP-43 and FUS and in spinal cord motor neurons from
sALS postmortem tissue. Our results confirm that expression of both mutant TDP-43 andmutant FUS cause
UPS dysfunction and alterations to Ub homeostasis. Furthermore, gene expression data from the ventral
horn of male patients with ALS suggests that these processes play an important role in the pathogenesis
of ALS (D’Erchia et al., 2017).
Ub-mediated protein degradation plays a vital role in maintaining proteostasis (Yerbury et al., 2016), and
the UPS has been shown to regulate the levels of ALS-associated proteins in cells (Scotter et al., 2014; Miya-
zaki et al., 2004), with proteasome inhibition resulting in the accumulation and aggregation of ubiquiti-
nated TDP-43 (Nonaka et al., 2009; van Eersel et al., 2011). Our previous work in NSC-34 cells established
that TDP-43 and FUS aggregates accumulate Ub late in comparison with SOD1 aggregates (Farrawell et al.,
2015), which contain Ub at the earliest stage of aggregation (Farrawell et al., 2018). Furthermore, we
confirmed that SOD1 aggregates contain both K48- and K63-linked polyubiquitin chains, targeting them
for degradation by the UPS and/or directing them for removal by autophagy, respectively (Farrawell
et al., 2018). In line with these results, we now show that TDP-43 and FUS aggregates contain both
K48- and K63-linked polyubiquitin chains. These results are consistent with previous work in human SH-
Figure 5. Free Ubiquitin Staining in NSC-34 Cells Expressing TDP-43 and FUS
(A) NSC-34 cells transfected with TDP-43-GFP or FUS-GFP were fixed, permeabilized, and stained for free Ub using the
free Ub sensor tUI-HA 48 h post-transfection. Scale bars, 20 mm.
(B) Violin plots of tUI-HA fluorescence in cells expressing either TDP-43-GFP or FUS-GFP calculated from high-throughput
image analysis using CellProfiler. Data shown are median, 25th and 75th quartiles with the width of the plot indicating
frequency (n = 139 TDP-43WT, n = 253 TDP-43M337V, n = 273 FUSWT, n = 335 FUSR495X). Statistical significance between
populations was determined using a Mann-Whitney U test.
(C) Cells expressing TDP-43M337V-GFP were further divided into soluble and insoluble populations via manual
segregation, and mean tUI-HA fluorescence was measured in ImageJ. Data are shown as a violin plot with median, 25th-
75th quartile and overall data range (n = 250 TDP-43WT, n = 221 TDP-43M337Vsoluble, n = 27 TDP-43M337V, insoluble).
Statistical significance was determined using Kruskal-Wallis test (*p < 0.05, **p < 0.01).
See also Figure S5.
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SY5Y cells, which demonstrated that both the UPS and autophagy pathway play a role in the clearance of
TDP-43 (Scotter et al., 2014). The presence of both UbK48 and UbK63 linkages suggests that K63 polyubiqui-
tin labeling may be directing aggregates to the Ub-aggresome route when the UPS is inhibited (Yamamoto
and Simonsen, 2011). Interestingly, cells expressing mutant FUS have increased levels of UbK48 in compar-
ison with cells expressing FUSWT (Kamelgarn et al., 2018), suggesting a dysfunctional UPS. These results
highlight the dependence on tightly regulated Ub homeostasis in neurons and are consistent with the
model that mutant ALS-associated proteins compromise UPS function and disrupt Ub homeostasis.
Figure 6. Ubiquitin Homeostasis in sALS
(A) Human ALS postmortem tissue was stained for both TDP-43 and Ub. Inclusions were imaged across two cases of sALS.
Representative images of motor neurons with the absence or presence of large skeins that colocalize to Ub staining are
shown. Scale bar, 10 mm.
(B) The mean fluorescence intensity of Ub associated with soluble and insoluble TDP-43 was quantified using ImageJ.
Data shown are meanG SD (n = 3) and statistical significance was determined using an unpaired Student’s t test (****p <
0.0001).
(C) Relative levels of Ub gene expression that were detected in microdissected ventral horn ALS spinal tissue (from
D’Erchia et al., 2017).
(D) Waterfall plot of relative expression or fold change of genes in the UPS and autophagy KEGG pathways.
Representative genes from three different regions are displayed.
(E) Key processes contributing to free Ub homeostasis and the difference in these processes in ALS compared with
control.
See also Figure S6, Tables S1 and S2.
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The UPS regulates cellular processes that are fundamental to the structure and function of the nervous
system (Mabb and Ehlers, 2010; Chen et al., 2011), and a dysfunctional UPS is thought to contribute to
the development of neurodegenerative disorders including ALS. Previously, using the proteasome re-
porter tdTomatoCL1, we have shown that the aggregation of SOD1A4V results in UPS dysfunction in
NSC-34 cells. Here, we show that this dysfunction is not specific to SOD1, as an accumulation of
tdTomatoCL1 was observed in cells expressing both TDP-43M337V and FUSR495X. In addition, we found
that the levels of UPS dysfunction in cells expressing TDP-43M337V were only significantly different to
cells expressing TDP-43WT at the highest concentration of MG132 tested. These results may also be
partly explained by the fact that overexpression of TDP-43WT is toxic to cells (Watanabe et al., 2013;
Yamashita et al., 2014; Park et al., 2017; Baskaran et al., 2018) and causes motor dysfunction and
death in mice (Becker et al., 2017). Furthermore, UPS inhibition causes the aggregation of both TDP-
43WT and mutant TDP-43 (Scotter et al., 2014), and the aggregation of TDP-43 leads to the accumulation
of the UPS reporter GFP-CL1 in SH-SY5Y cells (Nonaka et al., 2013). The UPS reporter UbG76V-GFP has
also been observed to accumulate in the motor neurons of SOD1G93A mice (Cheroni et al., 2009), high-
lighting that UPS dysfunction is a common feature of ALS. In fact, UPS dysfunction alone is sufficient to
drive ALS pathology, with the motor neuron-specific knockout of the proteasome subunit Rpt3 inducing
the aggregation of ALS-associated proteins and motor neuron degeneration in mice (Tashiro et al.,
2012).
The aggregation of ALS-associated proteins may exacerbate UPS dysfunction and alter Ub homeostasis
in cells by depleting the free Ub pool. We have previously shown that the UPS dysfunction observed in
NSC-34 cells containing SOD1A4V aggregates was associated with a redistribution of Ub and decreased
levels of free Ub (Farrawell et al., 2018). In this study, we show that the aggregation of mutant TDP-
43M337V and mutant FUSR495X also results in changes to Ub homeostasis through the redistribution of
Ub and depletion of the free Ub pool. Cellular Ub exists in dynamic pools where free Ub is maintained
at an adequate level in order to be able to respond to different cellular conditions (Park and Ryu, 2014).
Stress to the proteome causes dramatic changes to the Ub equilibrium by increasing the amount of
poly-ubiquitinated protein aggregates and decreasing the free Ub levels in cells (Salomons et al.,
2009). Inhibition of the UPS induces similar changes, with MG132 treatment resulting in the accumulation
of poly-ubiquitinated proteins and decreased rates of Ub diffusion (Dantuma et al., 2006). Consistent
with this, the aggregation of TDP-43M337V and FUSR495X led to changes in the mobility and kinetics of
Ub diffusion. Significant changes in Ub mobility were also observed in cells expressing FUSWT, but
this is consistent with the fact that the overexpression of FUSWT has been shown to alter the nuclear func-
tion of endogenous FUSWT (Sephton et al., 2014) and lead to the accumulation of Ub-positive deposits in
mice (Mitchell et al., 2013).
The accumulation of Ub in inclusions is a potential mechanism for Ub depletion, and previous studies
have suggested the effects of protein aggregation on Ub homeostasis will be similar regardless of which
protein is aggregated (Ben Yehuda et al., 2017). TDP-43 and FUS are both large components of ubiqui-
tinated inclusions in ALS tissue (Arai et al., 2006; Neumann et al., 2006), and here, we confirm through
multiple investigations that the aggregation of mutant TDP-43 and mutant FUS deplete the free Ub
pool. The consequences of Ub depletion in neurons can be dire, causing defects in neuronal outgrowth
and impaired synaptic development (Ryu et al., 2014), which, if prolonged, can lead to cell death.
Reduction in cellular Ub levels through disruption to the UBB poly-Ub gene gives rise to a progressive
neurodegenerative condition in mice (Ryu et al., 2008). Subsequent studies in these UBB-deficient mice
revealed that compensatory expression from the UBC gene is significantly upregulated in an attempt to
maintain free Ub levels and protect against neuronal dysfunction (Park et al., 2012). Interestingly, our
analysis of spinal cord tissue from patients with sALS revealed that the sequestration of Ub into inclusions
was not associated with a compensatory increase in Ub expression. In fact, compared with control tissue,
there was a decrease in the expression of UBB along with the decreased expression of Ub ligases and
DUBs. Modulation of Ub levels can also be achieved through overexpression or removal of Ub from pro-
tein aggregates. Overexpression of the DUB USP14 increases the amount of free Ub in cells (Hyrskyluoto
et al., 2014), and increasing free Ub levels through Ub overexpression was shown to improve the struc-
tural dysfunction in the neuromuscular junction of mice expressing a mutation in USP14 (Vaden et al.,
2015). Similarly, an ataxia-associated mutation in the UCHL1 gene has been associated with decreased
levels of monomeric Ub in the brains of mice, and overexpression of UCHL1 results in increased levels
of free Ub and improvements in synaptic function (Osaka et al., 2003; Gong et al., 2006). Overexpression
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of Ub has also been shown to enhance UPS function and reduce the cytosolic accumulation of TDP-43
and aggregation associated with UBQLN2 overexpression (Picher-Martel et al., 2019). Collectively, these
studies demonstrate that modulation of cellular Ub pools play an important role in the pathogenesis of
neurodegenerative diseases such as ALS. Moreover, although perturbations to Ub homeostasis appear
to be a unifying feature of ALS, it is likely treatment will have to be stratified based on the root cause of
the disruption.
In conclusion, we observe that the expression of mutant TDP-43 and mutant FUS causes UPS dysfunction,
where the aggregation of these proteins is associated with the redistribution of Ub and depletion of the
free Ub pool. Together with our previous observations in a SOD1 model, our findings suggest that pertur-
bations in Ub homeostasis may represent a common molecular pathway underlying neurodegeneration in
ALS across genetically distinct forms of the disease.
Limitations of the Study
Although NSC-34 cells exhibit many motor neuron characteristics and are routinely used to model
ALS, it should be noted that they are an immortalized mouse cell line. Furthermore, we are using a
transient transfection model to ectopically overexpress fluorescently tagged proteins. This type of
model recapitulates disease pathology but may not accurately reflect endogenous levels of protein in
post-mitotic neurons and restricts the bulk analysis of cell populations (e.g., by western blot), as
non-transfected cells influence the results. This work forms the basis of future research using human
iPSC-derived motor neurons and animal models to further investigate the importance of Ub homeostasis
in ALS.
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SUPPLEMENTAL FIGURES 
 
Figure S1. Proteasome inhibition with subinhibitory MG132 treatment has a modest impact on 
proteasome function in NSC-34 cells expressing tGFP control protein. Related to Figure 2. UPS 
function was analysed in the untransfected (UT) and GFP positive populations (tGFP) of NSC-34 cells 
co-transfected with tGFP and the fluorescent UPS reporter tdTomatoCL1, after overnight treatment (~18 
h) with increasing concentrations (0 - 30 µM) of the proteasome inhibitor MG132. Data represent mean 
tdTomatoCL1 fluorescence ± SEM (n=3). The transparent purple line indicates tdTomatoCL1 fluorescence 
levels in NSC-34 cells overexpressing TDP-43WT. Right inset displays an increased scale of 
tdTomatoCL1 fluorescence to illustrate the differences between the UT and tGFP populations. 
 
Figure S2. Representative confocal images of FRAP analysis performed in NSC-34 cells co-
expressing mCherry-Ub and TDP-43-GFP or FUS-GFP. Related to Figure 3. A ROI in the nucleus 
(A) or cytoplasm (B) of NSC-34 cells co-expressing mCherry-Ub and TDP-43-GFP or FUS-GFP was 
photobleached and the recovery of Ub fluorescence was monitored. Pre-bleach, post-bleach and 
recovery endpoint (final read) are shown with the ROI marked by a solid white circle. Scale bars: 10 
µm. 
 
Figure S3. Free ubiquitin levels are not significantly altered in NSC-34 cells containing TDP-
43M337V and FUSR495X compared to their WT controls. Related to Figure 4. (A) NSC-34 cells 
transfected with TDP-43WT-GFP, TDP-43M337V-GFP, FUSWT-GFP, FUSR495X-GFP or EGFP control were 
lysed in RIPA buffer and soluble and insoluble fractions were analysed for Ub levels by western blot. 
Quantitative assessment of (B) total Ub, (C) poly-Ub and (D) free Ub levels were analysed compared 
to (E) total protein using ImageJ software. Data represents mean ± SEM. (n=3 independent biological 
replicates).  A two-way ANOVA (variant x fraction) was performed to compare differences, which were 
not significant. 
 
 
Figure S4. Representative confocal images of FRANP analysis performed on NSC-34 cells co-
expressing mCherry-Ub and TDP-43-GFP or FUS-GFP. Related to Figure 4. The entire nucleus of 
NSC-34 cells co-expressing mCherry-Ub and TDP-43-GFP (A) or FUS-GFP (B) was photobleached 
and the recovery of Ub fluorescence was montitored. Pre-bleach, post-bleach and recovery endpoint 
(final read) are shown with the ROI (nucleus) marked by a solid white line. Scale bars: 10 µm. 
 
 
 
Figure S5. tUI-HA detects free Ub in NSC-34 cells. Related to Figure 5. (A) NSC-34 cells were fixed, 
permeabilised and stained for free Ub using the free Ub sensor tUI-HA (Choi et al., 2019) after 
incubation with the E1/UBA1 inhibitor TAK-243 (1µM) or DMSO control for the time period indicated. 
Scale bar represents 50 µm. (B) Violin plots of tUI-HA fluorescence in NSC-34 cells treated with TAK-
243 quantified using CellProfiler analysis. Data shown includes the median, 75th quartile and 25th 
quartile with the width of the density plot indicating frequency (Vehicle; n = 15,423, 2 h; n = 14,815, 4 
h; n = 17,667, 8 h; n = 19,082). Statistical significance was determined against vehicle control using a 
Kruskal-Wallis test with Dunn’s multiple comparisons (**** = p  < 0.001). 
 
 
 
 
Figure S6. Human ALS post mortem tissue was stained for TDP-43 and Ub. Related to Figure 6.  
(A) Spinal cord motor neurons from sALS post mortem tissue probed with TDP-43 (green) and Ub (red) 
for evidence of perturbed Ub homeostasis. Cell outline marked by a dashed white line. Scale bar = 10 
µm. (B) The intensity of Ub staining was calculated using ImageJ software (open source). The inclusion 
area was determined by setting a ‘default’ threshold and measuring the (pixel area and) mean pixel 
intensity. Diffuse (pixel area and) mean intensity were then measured by setting the maximum threshold 
to the value of the minimum threshold of an inclusion and setting a minimum threshold to a value that 
selects the remainder of the cell. 
  
SUPPLEMENTAL TABLES 
Table S1. UPS and autophagy related genes identified from the top 100 upregulated genes in ALS 
affected neurons relative to control neurons. Related to Figure 6. 
Genes up 
regulated 
log2 
(fold 
change) 
Functiona 
DDI1 4.293 Seems to act as a proteasomal shuttle linking proteasome and replication 
fork proteins  
USP26 3.231 DUBb 
UBE2C 2.466 E2 Ub conjugating enzyme 
ASB11 1.995 May be a substrate recognition component of a SCFc-like ECSd E3 
ubiquitin ligase complex 
PSMB11 1.898 Proteasome subunit 
IRGM 1.641 Regulates autophagy 
RNF133 1.607 E3 Ub ligase 
TRIM63 1.60 E3 Ub ligase 
ASB5 1.546 May be a substrate recognition component of a SCF-like ECS E3 
ubiquitin ligase complex 
ZBTB16 1.541 Probable substrate-recognition component of E3 Ub ligase complex 
UHRF1 1.42 E3 Ub ligase 
MAP1LC3C 1.233 Ub-like modifier involved in xenophagy and aggrephagy 
FBXO47 1.193 Probably recognises phosphorylated proteins and promotes their 
ubiquitination 
KLHL10 1.176 May be a substrate specific adaptor of a CUL3 based E3 Ub ligase 
DRAM1 1.148 Autophagy modulator 
SOCS1 1.142 Probable substrate recognition component of an ECS E3 Ub ligase 
TRIM22 1.12 E3 Ub ligase 
DTL 1.067 Component of a DCXe E3 Ub ligase 
ZNRF4 1.024 E3 Ub ligase 
TRIM6 1.002 E3 Ub ligase 
TRIM38 1.002 E3 Ub ligase 
TRIM71 0.867 E3 Ub ligase 
TRIM5 0.823 E3 Ub ligase 
ZNF645 0.796 E3 Ub ligase 
NEDD4 0.795 E3 Ub ligase 
SOCS3 0.793 Probable substrate recognition component of an ECS E3 Ub ligase 
RNF149 0.764 E3 Ub ligase 
TRIM21 0.732 E3 Ub ligase 
RNF135 0.721 E3 Ub ligase 
DDB2 0.691 Substrate recognition module for DCX E3 Ub ligase complex 
LRR1 0.675 Probable substrate recognition subunit of an ECS E3 Ub ligase 
FBXL8 0.671 Substrate-recognition component of the SCF type E3 Ub ligase complex 
ASB4 0.661 Probable substrate recognition component of a SCF-like ECS E3 ubiquitin 
ligase complex 
HSPB8 0.657 Heat shock protein molecular chaperone 
FBXO43 0.591 Probably recognises phosphorylated proteins and promotes their 
ubiquitination 
FBXO39 0.578 Substrate-recognition component of the SCF type E3 Ub ligase complex 
SOCS6 0.577 May be a substrate recognition component of a SCF-like ECS E3 Ub 
ligase 
RNF19A 0.574 E3 Ub ligase 
BIRC3 0.566 E3 Ub ligase 
TNFAIP3 0.559 DUB and Ub ligase activity 
PIAS1 0.554 Functions as an E3 type SUMOf ligase, promoting ubiquitin mediated 
degradation 
TRIM4 0.528 E3 Ub ligase 
TRIM47 0.522 E3 Ub ligase 
TRIM29 0.519 Induces K48 ubiquitination 
UBA7 0.504 E1 Ub activating enzyme 
a All functions sourced from UniProtKB/Swiss-Prot, b DUB: deubiquitinating enzyme, c SCF: Skp- 
Cullin-F-box containing complex, d ECS: Elongin-Cullin-SOCS Box Complex, e DCX: E3 ligase 
composed of DDB1-CUL4-X-box, f SUMO: small ubiquitin like modifier. Italicised genes are predicted 
to have roles in the UPS and/or autophagy. 
Table S2. UPS and autophagy related genes identified from the top 100 genes downregulated in ALS 
affected neurons relative to control neurons. Related to Figure 6. 
Genes down 
regulated 
log2 
(fold 
change) 
Function 
ASB18 -2.565 May be a substrate recognition component of a SCF-like ECS E3 
ubiquitin ligase complex 
HECW1 -2.109 E3 Ub ligase 
UCHL1 -1.867 DUB 
RNF128 -1.735 E3 Ub ligase 
USP6 -1.657 DUB 
TRIM36 -1.383 E3 Ub ligase 
LNX1 -1.360 E3 Ub ligase 
FBXO16 -1.314 Probably recognises phosphorylated proteins and promotes their 
ubiquitination 
TRIM58 -1.303 E3 Ub ligase 
UBE2O -1.197 E2 Ub conjugating enzyme 
ZSWIM2 -1.193 E3 Ub ligase 
FBXO41 
 
-1.188 Substrate-recognition component of the SCF type E3 Ub ligase complex 
FBXL16 -1.074 Substrate recognition component of a SCF-like ECS E3 ubiquitin ligase 
complex 
NEDD4L -1.03 E3 Ub ligase 
CDC20 -0.992 Required for full Ub ligase activity of APC/Cb 
HECW2 -0.896 E3 Ub ligase 
USP31 -0.884 DUB 
MAP1LC3A -0.862 Ub like modifier involved in formation of autophagosomes 
USP5 -0.84 DUB 
FBXO27 -0.781 Substrate recognition component of a SCF-like ECS E3 ubiquitin ligase 
complex 
UBE2S -0.776 E2 Ub conjugating enzyme 
TRIM37 -0.761 E3 Ub ligase 
TRIM2 -0.734 E3 Ub ligase 
FBXL18 -0.703 Substrate recognition component of a SCF-like ECS E3 ubiquitin ligase 
complex 
FBXO44 -0.701 Substrate recognition component of a SCF-like ECS E3 ubiquitin ligase 
complex 
UBB -0.640 Ubiquitin 
HECTD4 -0.638 E3 Ub ligase 
GABARAPL1 -0.637 Ub like modifier involved in formation of autophagosomes 
USP35 -0.633 DUB 
BTBD3 -0.630 Component of the 26S proteasome 
PSMD12 -0.606 Component of the 26S proteasome 
MAPK8IP1 -0.605 Regulator of autophagy 
UBE2T -0.598 E2 Ub conjugating enzyme 
RNF165 -0.584 E3 Ub ligase 
STUB1 -0.575 E3 Ub ligase 
HSPA8 -0.560 Heat shock protein molecular chaperone 
PSMB7 -0.555 Component of the 20S core proteasome 
NHLRC1 -0.530 E3 Ub ligase 
TRIM16 -0.526 E3 Ub ligase 
PRPF19 -0.523 E3 Ub ligase 
ATG4D -0.498 Autophagy required protease 
TRIM62 -0.498 E3 Ub ligase 
UBE4B -0.491 E3 Ub ligase 
RNF187 -0.480 E3 Ub ligase 
MAP1LC3B -0.480 Ub like modifier involved in formation of autophagosomes 
USP14 -0.480 DUB 
PSMB5 -0.476 Component of the 20S core proteasome 
TRIM41 -0.474 E3 Ub ligase 
FBXL19 -0.472 Substrate recognition component of a SCF-like ECS E3 ubiquitin ligase 
complex 
FBXO31 -0.471 Component of SCF like E3 ligase 
CBX4 -0.469 E3 SUMO ligase 
DCAF4 -0.469 May function as a substrate receptor for CUL4-DDB1 E3 Ub ligase 
OTUB1 -0.467 DUB 
PSMD8 -0.464 Component of the 26S proteasome 
FBXL22 -0.457 Substrate-recognition component of the SCF type E3 Ub ligase complex 
COPS5 -0.456 Regulator of Ub pathway by deneddylation os SCG-type E3 ligases 
FBXL14 -0.455 Substrate-recognition component of the SCF type E3 Ub ligase complex 
OTUB2 -0.453 DUB 
PINK1 -0.452 Mediates mitophagy 
RNF125 -0.452 E3 Ub ligase 
ULK2 -0.445 Mediates autophagy 
UBE2M -0.444 E2 conjugating enzyme 
ASB1 -0.441 Probable substrate recognition component of a SCF-like ECS E3 
ubiquitin ligase complex 
ULK1 -0.439 Mediates autophagy 
UBE3C -0.438 E3 Ub ligase 
PSMD4 -0.438 Component of the 26S proteasome 
ASB13 -0.437 May be a substrate recognition component of a SCF-like ECS E3 
ubiquitin ligase complex 
HSP90AA1 -0.436 Heat shock protein molecular chaperone 
a: All functions sourced from UniProtKB/Swiss-Prot, b APC/C: Anaphase promoting 
complex/cyclosome. Italicised genes are predicted to have roles in the UPS and/or autophagy. 
  
TRANSPARENT METHODS 
Plasmids 
Expression vector pCMV6-AC-tGFP containing human TDP-43 and FUS were obtained from OriGene 
(USA). mCherry-Ub and tdTomatoCL1 constructs were generated as described previously (Farrawell et 
al., 2018). The tUI-HA construct to express tUI-HA protein in Escherichia coli was acquired from 
Addgene (Addgene plasmid 122662, deposited by Robert Cohen; (Choi et al., 2019)). 
 
Antibodies 
The following antibodies were used in this study: rabbit monoclonal against UbK48 or UbK63 polymers 
(05-1307/05-1308, Merck Millipore; 1:500 dilution), mouse monoclonal anti-Ub antibody (MAB1510, 
Chemicon; 1:100 dilution), mouse monoclonal anti-Ub antibody (sc-8017, Santa Cruz Biotechnology; 
1:10,000 dilution), rabbit polyclonal anti-HA tag antibody (ab9110, Abcam; 1:1000 dilution), rabbit 
polyclonal anti-TDP-43 antibody (10782-2-AP, Proteintech; 1:1000 dilution), rabbit IgG polyclonal 
isotype control (ab171870, Abcam), Alexa Fluor 647-conjugated anti-rabbit-IgG secondary antibody 
(ab150079, Abcam; 1:1000 dilution), goat anti-mouse horseradish peroxidase conjugated secondary 
antibody (AP308P, Millipore; 1:5000 dilution). 
 
Expression and purification of tUI-HA 
Expression and purification of tUI-HA were carried out as reported previously (Choi et al., 2019) with 
alterations. The tUI-HA plasmid was transformed into chemically competent Rosetta BL21(DE3) pLysS 
cells using heat shock. Cells were grown in 2×YT medium to an optical density (600 nm) of 0.6 before 
expression was induced with 0.5 mM IPTG. After 8 hours of induction at 25 °C, cells were harvested by 
centrifugation at 3 200 ×g for 15 min at 4 °C and frozen at -20 °C until processing. Cell pellets were 
defrosted and resuspended in ice-cold lysis buffer (50 mM Tris, 500 mM NaCl, 30 mM Imidazole, 5 mM 
MgSO4, 200 µg/mL Lysozyme, 10 µg/mL DNase, pH 8) supplemented with Complete EDTA-free 
protease inhibitor cocktail (Sigma). The resuspension was then incubated on ice for 30 min with gentle 
rocking prior to undergoing sonication on ice (30% amplitude, 20 sec on, 60 sec off, repeated 5 times). 
Sonicated suspensions were aspirated through a 22 gauge needle before cell debris was cleared via 
centrifugation at 40 000 ×g for 20 min at 4 °C. Cleared lysate was filtered through a 0.22 µm syringe 
filter before being deposited onto Ni-NTA resin in 50 mL falcon tubes (5 mL resin per 25 mL cell lysate). 
Ni-NTA resin with lysate was mixed via rotation (20 rpm) at 4 °C for 1 h. Following this, Ni-NTA resin 
was pelleted via centrifugation at 4000 ×g for 5 min at 4 °C. The supernatant was aspirated from the 
Ni-NTA resin, and the resin was washed with binding buffer 5 times (50 mM Tris, 500 mM NaCl, 30 mM 
Imidazole, pH 8) 5 times (25 mL binding buffer, 5 min equilibration, 4000 g for 5 min at 4 °C  spins per 
wash). Following washing, the protein was dissociated from the Ni-NTA resin using 2 washes with 10 
mL of dissociation buffer (50 mM Tris, 500 mM NaCl, 300 mM Imidazole, pH 8). The dissociated protein 
was checked for purity via reducing SDS-PAGE prior to being dialyzed. Dialysis occurred overnight in 
5 L of 1× PBS at 4 °C with gentle stirring using SnakeSkin™ Dialysis Tubing, 3.5K MWCO 
(Thermofisher, USA). Dialyzed protein was filtered through a 0.22 µm syringe filter before being 
supplemented with glycerol (Sigma) to 15% (v/v) and TCEP (Sigma) to 0.5 mM. The concentration of 
the tUI-HA sensor was determined using UV/VIS spectroscopy (POLARStar Nano, BMG Labtech) at 
280 nm using an extinction coefficient of 22920 M-1cm-1  to be 3mg/mL(M.Walker, 2005). The tUI-HA 
probe was aliquoted and flash-frozen in liquid nitrogen before being stored at -80 °C. 
 
Cell culture and transfection 
Mouse neuroblastoma × spinal cord hybrid NSC-34 cells (a kind gift from Professor Neil Cashman, 
University of British Columbia, Canada) (Cashman et al., 1992) were cultured in Dulbecco’s Modified 
Eagle’s Medium/Ham’s Nutrient Mixture F12 (DMEM-F12) DMEM-F12 containing 10% FBS (Gibco) 
and were maintained at 37 °C  in a humidified incubator with 5 % atmospheric CO2. Cell were plated 
out on to multi-well plates or plastic 8-well µslides (Ibidi, Germany) at ~ 50 % confluency 24 h prior to 
transfection with Lipofectamine 3000 (Invitrogen, USA) or TransIT-X2 transfection reagent (Mirus Bio, 
USA). Transfections were carried out according to manufacturer’s instructions. For co-transfections, the 
amount of DNA was divided equally between constructs.  
 
Immunofluorescence 
Staining of NSC-34 cells was performed according to Farrawell et al. (2018). NSC-34 cells grown on 
coverslips in 24-well plates were transfected with TDP-43-GFP or FUS-GFP and fixed 48 h post-
transfection with 4% paraformaldehyde (PFA) in PBS for 20 min at room temperature (RT). Following 
permeabilization with 1 % Triton X-100 (TX-100) in PBS on ice for 30 min, cells were blocked with 5 % 
FBS, 1 % bovine serum albumin (BSA), 0.3 % TX-100 in PBS for 1 h at RT. Cells were then incubated 
with primary antibodies against UbK48 or UbK63 polymers (1:500 dilution in 1 % BSA, 0.1 % TX-100 in 
PBS) overnight at 4 °C. The following day, cells were incubated with anti-rabbit IgG secondary antibody 
(1:500 dilution in 1 % BSA, 0.1 % TX-100 in PBS) for 5 h at RT before mounting coverslips onto slides 
using ProLong Diamond Antifade Mountant (Molecular Probes) and imaging on a Leica SP5 confocal 
microscope. 
Immunostaining of post mortem tissue (obtained from the Australian Brain Bank Network) was 
performed as outlined previously (Farrawell et al., 2015). Spinal cord  tissue sections (5 µm) from two 
sALS cases were treated with xylene and rehydrated with a series of decreasing dilutions of ethanol 
and water before antigen retrieval by heating in 10mM citrate buffer (pH 6.0). Sections were blocked 
with 1 % BSA before overnight incubation with primary antibodies (rabbit polyclonal anti-TDP-43 
antibody (10782-2-AP, Proteintech) and mouse monoclonal anti-ubiquitin antibody (MAB1510, 
Chemicon)), followed by a 1 h incubation at RT with secondary antibodies (anti-rabbit conjugated Alexa 
Fluor 488 and anti-mouse conjugated Alexa Fluor 555). Confocal fluorescence imaging was performed 
using a Leica DM6000 upright laser scanning confocal microscope using Leica application suite 
advanced fluorescence software. Images were acquired with a 40× oil immersion objective in sequential 
mode to avoid crosstalk between two dyes. 
 
Free Ub levels were measured in NSC-34 cells expressing TDP-43-GFP or FUS-GFP using the high-
affinity free Ub sensor tUI-HA (Choi et al., 2019). Cells grown in 8-well µslides (Ibidi) were subjected to 
a short prefix step 48 h post-transfection with 2% PFA (pre-warmed to 37°C) for 5 min before fixing with 
4% PFA at RT for 15 min. Cells were washed with 100 mM Tris pH 8.0 before permeabilization with 
0.1% TX-100 in PBS. Cells were then blocked for 1 h at RT with blocking buffer (10% FBS, 2% BSA, 
0.1% TX-100 in PBS) before incubating with the tUI-HA probe diluted 1:400 (7.5 µg/mL) in blocking 
buffer for 30 min at RT. Cells were incubated with anti-HA antibody in blocking buffer for 1 h at RT, or 
overnight at 4 °C, and washed three times with PBS before incubating with Alexa Fluor 647-conjugated 
secondary antibody in blocking buffer for 1 h at RT. Finally, cells were stained with ActinRed-555™ 
(Thermo Scientific) in PBS for 30 min at RT  before being counterstained with Hoechst 33342 nucleic 
acid stain (diluted 1:5000 in PBS) for 5 min at RT, washed twice in PBS, and imaged using an SP8 
confocal microscope. To determine the sensitivity and specificity of tUI-HA to free Ub, NSC-34 cells 
were treated (or not) with 1 µM of the E1/UBA1 inhibitor TAK-243 (ChemieTek, USA) for varying times 
(2, 4, or 8 h) prior to being fixed and stained with the tUI-HA probe as outlined above. 
 
UPS activity assay 
UPS activity was measured in cells expressing TDP-43-GFP or FUS-GFP using the fluorescent 
proteasome reporter tdTomatoCL1, as described previously (Farrawell et al., 2018). In summary, 
transfected NSC-34 cells were incubated with increasing concentrations (0 - 30 µM) of the proteasome 
inhibitor, MG132, for 18 h before harvesting 48 h post-transfection for analysis by flow cytometry on a 
LSRFortessa X‐20 Cell Analyzer (BD Biosciences). The excitation wavelengths and collection windows 
used to measure the fluorescence intensity of tGFP and tdTomatoCL1 were 488 nm, 525/50 nm and 561 
nm, 558/15 nm, respectively. Analysis was performed using FlowJo version 10 (FlowJo LLC, USA) and 
compensation was applied using the in-built compensation wizard before cells were gated based on 
tGFP fluorescence and the mean tdTomatoCL1 fluorescence was measured. Mean tdTomatoCL1 
fluorescence was also measured in the untransfected (UT, GFP negative) population of cells co-
transfected with tGFP to assess the impacts of MG132 treatment and the overexpression of a non-
pathogenic protein on UPS function. 
 
Confocal microscopy 
Fluorescence recovery after photobleaching (FRAP) and fluorescence recovery after nuclear 
photobleaching (FRANP) experiments were performed on NSC-34 cells co-expressing mCherry-Ub and 
TDP-43-GFP or FUS-GFP 48 h post-transfection using the LASAF FRAP application wizard on an SP5 
confocal microscope, as described previously (Farrawell et al., 2018). Briefly, to bleach mCherry-Ub, 
five pre-bleach 512 x 512 images were acquired over 7. 5 s using a 63× 1.2NA water-immersion 
objective at a scan speed of 700 Hz before the region of interest (ROI) was bleached using the 'zoom 
in ROI' method over five (1.5 s) frames with the 561 nm laser power set to 100%. Recovery of mCherry-
Ub into the ROI was monitored over 120 s with the laser power set at 20%. For FRAP experiments, the 
ROI was set at ~ 2 µm in diameter in the nucleus or cytoplasm of cells. 
 
To quantify tUI-HA staining, cells were imaged on an SP8 confocal (Leica) where Hoechst 33482 was 
excited with a 405 nm laser, Actin-555 was excited with a 552 nm laser, and Alexa Fluor 647 (tUI-HA) 
was excited with a 638 nm laser. Images (12-bit) were acquired using the 40× 1.3NA oil-immersion 
objective, one line and frame average at a scan speed of 400 Hz. To segregate cells containing 
insoluble TDP-43M337V-GFP inclusions or quantify tUI-HA fluorescence in cells treated with TAK-243, 
16-bit resolution images in 1024 x 1024 format were acquired in 4 x 4 tilescans as z-stacks (17 slices 
or 20 µm) using the HC PL Fluotar 20× air objective (NA 0.55) with a scan speed of 200 Hz. Images 
were subsequently processed using CellProfiler software (Version 3.1.8) (McQuin et al., 2018) and 
ImageJ 1.52p (Schneider et al., 2012). 
 
Image analysis for measuring Ub signal associated with inclusions 
Image analysis to quantify the Ub signal associated with insoluble ALS-associated inclusions was 
performed using ImageJ software as described previously (Pokrishevsky et al., 2018). Briefly, the ROI 
within a cell consisting of aggregated TDP-43 or FUS was defined by setting a 'default' threshold in the 
GFP image. This ROI was subsequently applied to the mCherry image, and the mean pixel intensity 
was measured. The mean pixel intensity was also calculated for the remaining area of the cell 
containing diffuse protein by altering the maximum threshold in the GFP image to the minimum 
threshold set for the aggregated protein.  
 
Quantification of tUI-HA fluorescence 
A CellProfiler pipeline was developed to measure tUI-HA fluorescence in TDP-43-GFP and FUS-GFP 
expressing cells from images generated by the confocal microscope. Firstly, images were smoothed 
and then primary objects (nuclei) were identified based on size (10-50 pixel units) and minimum cross 
entropy thresholding. The nuclei were subsequently used to identify the secondary objects (cells) 
through propagation and adaptive thresholding in the ActinRed-555 channel. The GFP fluorescence 
intensity in the cells was then measured so they could be filtered to identify 'GFP positive' cells. 
Following filtering, tUI-HA fluorescence was measured in the 'GFP positive' cells, and the data was 
exported to a spreadsheet. 
 
For cells treated with TAK-243, a separate CellProfiler pipeline was developed to produce max intensity 
and summed intensity projections of z-stacks for all images. Nuclei were identified using the StarDist 
plugin(Schmidt et al., 2018) for ImageJ using a script for batch processing. Stardist nuclei were used 
as primary objects in the CellProfiler pipeline where the whole cell was identified by propagation in the 
Actin-555 channel. Whole cell ROIs were applied to the tUI-HA images, and the mean intensity per cell 
was measured. 
 
To measure tUI-HA fluorescence in cells containing insoluble TDP-43M337V-GFP aggregates, summed 
intensity projections were generated using CellProfiler and subsequently manually processed using 
ImageJ software. Firstly, images from the GFP channel (TDP-43-GFP or FUS-GFP images) were 
thresholded to remove background, and the magic wand tool was used to manually segment cells and 
set ROIs based on fluorescence. These ROIs were applied to the tUI-HA images before the mean tUI-
HA fluorescence intensity was measured.  
 
Protein-Protein interactions  
Protein-protein interactions and KEGG pathway analysis among the resulting protein list generated from 
microdissected ventral horn ALS spinal tissue (from D'Erchia et al. 2017) were analyzed using STRING 
(v10) (Szklarczyk et al., 2015) (with a confidence score of 0.700). 
 
Cell lysis and fractionation 
NSC-34 cells grown in 6-well plates were transfected with TDP-43-GFP, FUS-GFP or EGFP and 
harvested 48 h post-transfection with Trypsin/EDTA (Gibco). Cells were washed with PBS and each 
well was lysed in 100 µl of RIPA buffer [50mM Tris-HCl pH7.4, 1% (w/v) sodium deoxycholate, 150 mM 
NaCl, 1 mM EDTA, 1% (v/v) TX-100, 0.1% (w/v) SDS] containing protease inhibitors (Halt™ Protease 
Inhibitor Cocktail (Thermo Scientific)) and 10 mM N-Ethylmaleimide (NEM). Samples were briefly 
sonicated before centrifugation at 21 000 ×g at 4 °C for 1 h. The supernatant was collected as the 
'soluble fraction' and the insoluble pellet was resuspended in urea buffer [7M Urea, 4% (w/v) CHAPS, 
30 mM Tris pH 8.5] to create the 'insoluble fraction'. The insoluble fraction samples were sonicated in 
a sonicating waterbath for 10 min before protein concentration was determined using a BCA assay. 
 
Western blotting 
Soluble and insoluble fractions were reduced with 2.5% β-mercaptoethanol and heated for 10 mins at 
70 °C. 15 µg of each sample was loaded and separated onto Any-kDa Mini-PROTEAN TGX Stain-Free 
precast gels (BioRad) and subsequently transferred onto PDVF membrane (0.2 µm pore size). 
Membranes were imaged with a GelDoc XR+ imager (BioRad) to obtain a total protein measurement 
for each sample before incubation with blocking solution containing 5% skim milk powder (w/v) in Tris-
Buffered Saline with Tween-20 (TBST) for 1 h at RT. Membranes were probed with mouse monoclonal 
anti-Ub antibody (sc-8017, Santa Cruz Biotechnology, 1:10,000 dilution in blocking buffer) overnight at 
4 °C. Subsequently, membranes were incubated goat anti-mouse horseradish peroxidase-conjugated 
secondary antibody (AP308P, Millipore, 1:5000) for 1 h at RT. Bands were visualized by briefly 
incubating membrane in Amersham ECL Western blotting detection reagent (GE Healthcare) and 
imaged with Amersham 600RB Imager (GE Healthcare). Relative Ub levels for each sample were 
quantified using ImageJ gel analysis tools and normalized to their respective total protein measurement 
and an internal control sample (containing equal amounts of each sample), to account for protein 
loading and gel-to-gel variability. 
 
Statistics 
All statistical analyses were performed using GraphPad Prism software version 5.00 or 8.4.2 for 
Windows (GraphPad Software, USA). Specific details of analyses are provided in relevant figure 
captions. 
SUPPLEMENTAL REFERENCES 
CASHMAN, N. R., DURHAM, H. D., BLUSZTAJN, J. K., ODA, K., TABIRA, T., SHAW, I. T., 
DAHROUGE, S. & ANTEL, J. P. 1992. Neuroblastoma x spinal cord (NSC) hybrid cell lines 
resemble developing motor neurons. Dev. Dyn., 194, 209-221. 
M.WALKER, J. 2005. The Proteomics Protocols Handbook | Springer. 
MCQUIN, C., GOODMAN, A., CHERNYSHEV, V., KAMENTSKY, L., CIMINI, B. A., KARHOHS, K. 
W., DOAN, M., DING, L., RAFELSKI, S. M., THIRSTRUP, D., WIEGRAEBE, W., SINGH, S., 
BECKER, T., CAICEDO, J. C. & CARPENTER, A. E. 2018. CellProfiler 3.0: Next-generation 
image processing for biology. PLoS Biol., 16, e2005970. 
POKRISHEVSKY, E., MCALARY, L., FARRAWELL, N. E., ZHAO, B., SHER, M., YERBURY, J. J. & 
CASHMAN, N. R. 2018. Tryptophan 32-mediated SOD1 aggregation is attenuated by 
pyrimidine-like compounds in living cells. Sci. Rep., 8, 15590. 
SCHMIDT, U., WEIGERT, M., BROADDUS, C. & MYERS, G. 2018. Cell Detection with Star-Convex 
Polygons. Medical Image Computing and Computer Assisted Intervention - Miccai 2018, Pt Ii, 
11071, 265-273. 
SCHNEIDER, C. A., RASBAND, W. S. & ELICEIRI, K. W. 2012. NIH Image to ImageJ: 25 years of 
image analysis. Nat Methods, 9, 671-5. 
SZKLARCZYK, D., FRANCESCHINI, A., WYDER, S., FORSLUND, K., HELLER, D., HUERTA-
CEPAS, J., SIMONOVIC, M., ROTH, A., SANTOS, A., TSAFOU, K. P., KUHN, M., BORK, P., 
JENSEN, L. J. & VON MERING, C. 2015. STRING v10: protein-protein interaction networks, 
integrated over the tree of life. Nucleic Acids Res, 43, D447-52. 
 
